These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11416945)

  • 1. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
    Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
    Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
    O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
    Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease].
    Arbizu J; Larumbe R; Gámez C; Martí J; Martínez-Lage J; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):252-60. PubMed ID: 10481106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.
    Borroni B; Premi E; Agosti C; Alberici A; Cerini C; Archetti S; Lanari A; Paghera B; Lucchini S; Caimi L; Padovani A
    J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):834-8. PubMed ID: 21345847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?
    Sundström T; Elgh E; Larsson A; Näsman B; Nyberg L; Riklund KA
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):73-80. PubMed ID: 16151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
    Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
    J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia.
    Boutoleau-Bretonnière C; Lebouvier T; Delaroche O; Lamy E; Evrard C; Charriau T; Bretonnière C; Damier P; Derkinderen P; Vercelletto M
    J Alzheimers Dis; 2012; 28(2):323-36. PubMed ID: 22008265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT patterns in probable Alzheimer's disease.
    Müller H; Möller HJ; Stippel A; Fric M; Grünwald F; Laux G; Klemm E; Biersack HJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(4):190-6. PubMed ID: 10449594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
    Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease.
    Kouzuki M; Asaina F; Taniguchi M; Musha T; Urakami K
    Psychogeriatrics; 2013 Jun; 13(2):63-70. PubMed ID: 23909962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment.
    Osimani A; Ichise M; Chung DG; Pogue JM; Freedman M
    Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.